Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Starting March 2020 the Italian Government imposed a lockdown to limit the spread of SARS-CoV-2. During lockdown outpatient visits were limited and telemedicine (TM) was encouraged. Methods: We retrospectively analyzed data from continuous or flash glucose monitoring systems shared through different cloud systems during the lockdown by subjects with type 1 diabetes and compared data obtained 4 weeks before and 4 weeks after structured telephonic visit. Variables considered were mean glucose, time spent in target (70–180 mg/dl), hypoglycemia (<70 mg/dl) and hyperglycemia (>180 mg/dl), coefficient of variation, and length of sensor use. Results: During the 4 weeks following the telephonic visit there was an improvement of glycemic control, with a significant reduction of mean glucose values (161.1 before vs 156.3 mg/dl after, p = 0.001), an increase of the time spent in target (63.6 vs 66.3, p = 0.0009) and a reduction of time spent in hyperglycemia (33.4 vs 30.5, p = 0.002). No changes were observed regarding glucose variability, time spent in hypoglycemia, and length of sensor use. Similar results were observed in subjects treated with multiple daily injections or continuous subcutaneous insulin infusion. Conclusions: A structured telephonic visit appears to be an effective way to replace or integrate routine visits in particular conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Continuous glucose monitoring sensors: past, present and future algorithmic challenges
Facchinetti, A. (2016) · Sensors · doi:10.3390/s16122093 · Cited by 176 · cited 1×
“Sensors 16, 2093 (2016).”
Cited by
Telehealth utilization during the Covid-19 pandemic: a systematic review
Garfan, S., Alamoodi, A. H., Zaidan, B. B., Al-Zobbi, M., Hamid, R. A., Alwan, J. K., Ahmaro, I. Y. Y., Khalid, E. T., Jumaah, F. M., Albahri, O. S., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104878 · Cited by 369
Omboni, S., Ballatore, T., Rizzi, F., Tomassini, F., Panzeri, E., & Campolo, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258015 · Cited by 51
The feasibility, acceptability, and usability of telehealth visits
Sinha Gregory, N., Shukla, A. P., Noel, J. J., Alonso, L. C., Moxley, J., Crawford, A. J., Martin, P., Kumar, S., Leonard, J. P., & Czaja, S. J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1198096 · Cited by 33
Metadata
- Authors
- Boscari, F., Ferretto, S., Uliana, A., Avogaro, A., & Bruttomesso, D.
- Venue
- Nutrition & Diabetes
- Published
- 2021-01-05
- Volume
- 11
- Issue
- 1
- Pages
- 1-1
- ISSN
- 2044-4052 (ISSN-L)
- OpenAlex
- W3120137378
- Cited by
- 39
- References
- 4
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown. https://app.cochat.ai/papers/10.1038/s41387-020-00147-8
- The paper
- Boscari, F., Ferretto, S., Uliana, A., Avogaro, A., & Bruttomesso, D. (2021). Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown. Nutrition & Diabetes. https://doi.org/10.1038/s41387-020-00147-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.